Table 1. ACR Paediatric 30 Responses, Week 12

JIA Subtype	% Subjects (95% CI)		ETN 0.8 mg/kg vs. Placebo Historical Data
	ETN 0.8 mg/kg	Placebo Historical data	Odds Ratio (95% CI)
Overall, n=123	88.6 (81.6–93.6)	28.9 (24.0–34.2)^a	23.5 (12.5–44.3)
eoJIA, n=58	89.7 (78.8–96.1)	28.9 (24.0–34.2)^a	26.2 (10.6–64.2)
ERA, n=36	83.3 (67.2–93.6)	28.9 (24.0–34.2)^a	15.1 (6.0–38.2)
ERA, n=36	83.3 (67.2–93.6)	42.8 (16.9–68.8)^b	6.7 (1.7–26.3)
PsA, n=29	93.1 (77.2–99.2)	28.9 (24.0–34.2)^a	40.7 (9.4–176.9)

Modified intent-to-treat (mITT) population (observed cases). ^aMeta-analysis weighted estimate of placebo response rate in Ruperto et al. [1]. ^bPlacebo response rate in Burgos-Vargas et al. [2].